Platelet Rich Plasma (PRP) Market Strategy and Growth Factor Report by 2024: Arthrex, Inc., Stryker Corporation, Johnson and Johnsons Ltd
May 28, 2019 at 11:05 AM EDT
Valley Cottage, NY -- (SBWIRE) -- 05/28/2019 -- The market for platelet rich plasma (PRP) Europe is expected to reach US$ 37.5 Mn in 2016, up from US$ 35.3 Mn in 2015. Adoption of platelet rich plasma in treating musculoskeletal injuries, including tennis elbow, Achilles tendinopathy, and plantar fasciitis, will continue to drive revenues. PRP therapy is also gaining traction in treating sports-related and geriatric injuries, owing to its minimally invasive procedure and quicker recovery time.
